MiR-186 represses progression of renal cell cancer by directly targeting CDK6
In conclusion, miR-186 suppresses proliferation, migration and invasion of RCC by inhibiting CDK6 expression.
Source: Human Cell - Category: Cytology Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Cytology | Epithelial Cancer | Genetics | Kidney Cancer | Renal Cell Carcinoma | Study